We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.67B
AUM Growth
+$240M
Cap. Flow
+$105M
Cap. Flow %
3.94%
Top 10 Hldgs %
17.98%
Holding
319
New
17
Increased
107
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$15M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.58M
3
ACN icon
Accenture
ACN
+$7.15M
4
AVGO icon
Broadcom
AVGO
+$6.73M
5
ADP icon
Automatic Data Processing
ADP
+$6.53M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19.1M
3
MDSO
Medidata Solutions, Inc.
MDSO
+$7.95M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.33M
5
BDX icon
Becton Dickinson
BDX
+$3.8M

Sector Composition

Rank Sector Weight
1 Technology 25.98%
2 Healthcare 19.42%
3 Industrials 19.08%
4 Consumer Discretionary 11.89%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVGW
126
DELISTED
Calavo Growers
CVGW
$5.24M 0.2%
54,200
– –
BAC icon
127
Bank of America
BAC
$433B
$5.22M 0.2%
180,000
-115,000
-39% -$3.32M
LEN icon
128
Lennar Class A
LEN
$20.2B
$5.09M 0.19%
108,465
+5,165
+5% +$258K
EA icon
129
Electronic Arts
EA
$52.9B
$5.06M 0.19%
50,000
-3,000
-6% -$286K
SPSC icon
130
SPS Commerce
SPSC
$2.42B
$5.04M 0.19%
98,600
– –
TECD
131
DELISTED
Tech Data Corp
TECD
$5.02M 0.19%
48,000
– –
BHVN
132
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.82M 0.18%
+110,000
New +$6.2M
EVBG
133
DELISTED
Everbridge, Inc. Common Stock
EVBG
$4.77M 0.18%
53,300
+15,200
+40% +$1.2M
MIDD icon
134
Middleby
MIDD
$6.03B
$4.64M 0.17%
34,200
– –
EQIX icon
135
Equinix
EQIX
$103B
$4.64M 0.17%
9,200
+1,500
+19% +$720K
LECO icon
136
Lincoln Electric
LECO
$13.7B
$4.64M 0.17%
56,319
-27,700
-33% -$2.3M
CASY icon
137
Casey's General Stores
CASY
$32.1B
$4.6M 0.17%
29,500
-19,400
-40% -$2.65M
KWR icon
138
Quaker Houghton
KWR
$2.69B
$4.58M 0.17%
22,600
+7,500
+50% +$1.52M
Y
139
DELISTED
Alleghany Corp
Y
$4.56M 0.17%
6,700
– –
AON icon
140
Aon
AON
$78.3B
$4.55M 0.17%
23,600
+12,600
+115% +$2.28M
JBHT icon
141
JB Hunt Transport Services
JBHT
$25.3B
$4.54M 0.17%
49,700
– –
ZTS icon
142
Zoetis
ZTS
$31.9B
$4.54M 0.17%
40,000
– –
BMY icon
143
Bristol-Myers Squibb
BMY
$132B
$4.54M 0.17%
100,000
+30,000
+43% +$1.4M
BKNG icon
144
Booking.com
BKNG
$150B
$4.5M 0.17%
60,000
– –
LFUS icon
145
Littelfuse
LFUS
$11.2B
$4.48M 0.17%
25,300
– –
JPM icon
146
JPMorgan Chase
JPM
$933B
$4.47M 0.17%
40,000
-4,000
-9% -$441K
MU icon
147
Micron Technology
MU
$988B
$4.44M 0.17%
115,000
+15,000
+15% +$572K
WRB icon
148
W.R. Berkley
WRB
$27.2B
$4.42M 0.17%
150,750
+12,375
+9% +$339K
UNH icon
149
UnitedHealth
UNH
$383B
$4.34M 0.16%
17,800
– –
PAYC icon
150
Paycom
PAYC
$7.53B
$4.33M 0.16%
19,100
+900
+5% +$185K
4 5
6
7 8

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, EULAV Asset Management held 319 positions worth $2.67B, up 9.9% from $2.43B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EULAV Asset Management deployed $105M of net new capital in Q2 2019, opening 17 new positions and adding to 107 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $5.33M trimmed.

  • EULAV Asset Management's largest Q2 2019 buy was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.
  • EULAV Asset Management added most to Union Pacific in Q2 2019, an estimated $15M increase.
  • EULAV Asset Management's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $5.33M.
  • EULAV Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $23M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $2.67B portfolio in Q2 2019.
  • EULAV Asset Management opened 17 new positions and closed 13 in Q2 2019.
  • EULAV Asset Management's portfolio value rose 9.9% quarter-over-quarter to $2.67B.

Based on EULAV Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.